Advertisement

Positron Emission Tomography in Diagnosing Lung Tumors

  • Kazuo Kubota
  • Susumu Yamada
  • Masatoshi Ito
  • Kenji Yamada
  • Takehiko Fujiwara
  • Roko Kubota
  • Kiichi Ishiwata
  • Hiroshi Fukuda
  • Taiju Matsuzawa
  • Masao Tada
  • Tatsuo Ido
Part of the Developments in Nuclear Medicine book series (DNUM, volume 28)

Abstract

Lung cancer is the leading cause of death in many countries. In Japan the mortality of stomach cancer has begun to decrease while that of lung cancer is still increasing (1991: 21% of all cancer deaths in male and 11.5% in female). The reasons for this situation are not only high incidence but also poor prognosis. Significant improvements are expected in all aspects of disease management: detection, diagnosis, staging, treatment, and treatment evaluation.

Keywords

Positron Emission Tomography Tumor Uptake High Resolution Compute Tomography Bronchogenic Carcinoma Solitary Pulmonary Nodule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Proto AV, Thomas SR. Pulmonary nodules studied by computed tomography. Radiology 1985; 156: 149–153.PubMedGoogle Scholar
  2. 2.
    Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonarynodule: a cooperative study. Radiology 1986; 160: 319–327.PubMedGoogle Scholar
  3. 3.
    Siegelman SS, KhouriNF, Leo FP, Fishman EK, Braverman RM, Zerhouni EA. Solitary pulmonary nodules: CT assessment. Radiology 1986; 160: 307–312.PubMedGoogle Scholar
  4. 4.
    Zwirewick CV, Vedal S, Millar RR, Mueller NL. Solitary pulmonary nodule: high resolution CT and radiologie pathologic correlation. Radiology 1991; 179: 469–476.Google Scholar
  5. 5.
    Huston J, Muhm JR. Solitary pulmonary nodules: evaluation with a CT reference phantom. Radiology 1989; 170: 653–656.PubMedGoogle Scholar
  6. 6.
    Staples CA, Mueller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988; 167: 367–372.PubMedGoogle Scholar
  7. 7.
    McLoud TC, Bourgouin PM, Greenberg RW et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymphnode mapping and sampling. Radiology 1992; 182: 319–323.PubMedGoogle Scholar
  8. 8.
    Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nuel Med 1994; 21: 57–81.Google Scholar
  9. 9.
    Tonami N, Shuke N, Yokoyama K,et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30: 997–1004.PubMedGoogle Scholar
  10. 10.
    Kubota K, Matsuzawa T, Ito M, et al. Lung tumor imaging by positron emission tomography using C-11-L-methionine. J Nucl Med 1985; 26: 37–42.PubMedGoogle Scholar
  11. 11.
    Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of solitary pulmonary nodules with positron emission tomography. J Comput Assist Tomogr 1988; 12: 794–796.PubMedCrossRefGoogle Scholar
  12. 12.
    Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990; 31: 1927–1933.PubMedGoogle Scholar
  13. 13.
    Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682–2689.PubMedCrossRefGoogle Scholar
  14. 14.
    Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623–648.PubMedGoogle Scholar
  15. 15.
    Jacobs MP, Mantil JC, Peterson CD, et al. FDG PET imaging of the chest. J Nucl Med 1992; 33: 975.Google Scholar
  16. 16.
    Wahl RL, Quint LE, Orringer M, Meyer CH. Staging non-small cell lung cancer in the mediastinum: comparison of FDG-PET, CT and hybrid anatometabolic fusion images with pathology. Radiology 1992; 185 (p): 324.Google Scholar
  17. 17.
    Slosman DO, Spiliopoulos A, Couson F, et al. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Comm 1993; 14: 955–961.CrossRefGoogle Scholar
  18. 18.
    Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487–490.PubMedGoogle Scholar
  19. 19.
    Gupta N, Chandramouli B, Reeb S, Dewan N. Diagnostic evaluation of solitary pulmonary nodules. J Nucl Med 1994; 35: 76P, Radiology 1992; 184: 441–444, Chest 1993; 104: 997–1002.Google Scholar
  20. 20.
    Hubner KF, Smith GT, Raja S, Hunter K, Gould HR, Buonocore E. Positron emission tomography for evaluating chest masses. J Nucl Med 1994; 35: 220 P.Google Scholar
  21. 21.
    Coleman RE, Cascade E, Gupta NC, Lawson M, Patz E, Rubin RJ. Clinical application and economic implications of PET in assessment of solitary pulmonary nodules: a retrospective study. 1994 Institute for clinical PET, Fairfax VA, USA.Google Scholar
  22. 22.
    Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flowcytometric parameters. J Nucl Med 1993; 34: 1886–1891.PubMedGoogle Scholar
  23. 23.
    Knopp MV, Strauss LG, Bischoff H, et al. Assessment of the potential clinical role of PET in the staging of thoracic adenopathy. Radiology 1991; 181P: 250.Google Scholar
  24. 24.
    Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG-PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371–377.PubMedGoogle Scholar
  25. 25.
    Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993; 72: 82–90.PubMedCrossRefGoogle Scholar
  26. 26.
    Lewis PJ and Salama A. Uptake of fluorine-l8-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35: 1647–1649.PubMedGoogle Scholar
  27. 27.
    Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-l8-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972–1980.PubMedGoogle Scholar
  28. 28.
    Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 1994; 35: 164–167.PubMedGoogle Scholar
  29. 29.
    Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with (fluorine-18)-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189: 847–850.PubMedGoogle Scholar
  30. 30.
    Langen KJ, Braun U, Kops R, et al. The influence of plasma glucose levels on fluorine-l8-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355–359.PubMedGoogle Scholar
  31. 31.
    Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308–1312.PubMedGoogle Scholar
  32. 32.
    Lindholm P, Leskinen-Kallio S, Kirvela O, et al. Head and neck cancer: effect of food ingestion on uptake of C-11 methionine. Radiology 1994; 190: 863–867.PubMedGoogle Scholar
  33. 33.
    Kubota K, Matsuzawa T, Takahashi T, et al. Rapid and sensitive response of carbon11-L-methionine tumor uptake to irradiation. J Nucl Med 1989; 30: 2012–2016.PubMedGoogle Scholar
  34. 34.
    Kubota K, Ishiwata K, Yamada S, et al. Dose-responsive effect of radiotherapy on the tumor uptake of L-methyl-11-C methionine; feasibility for monitoring recurrence of tumor. Nucl Med Biol 1992; 19: 27–32.Google Scholar
  35. 35.
    Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-l8-fluorodeoxyglucose or fluorine18-fluorodeoxyuridine, L-methyl-14C methionine,6–3H thymidine, and Gallium-67.J Nucl Med 1991; 32: 2118–2123.PubMedGoogle Scholar
  36. 36.
    Kubota K, Kubota R, Yamada S. FDG accumulation in tumor tissue (Editorial). J Nucl Med 1993; 34: 419–421.PubMedGoogle Scholar
  37. 37.
    Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 1992; 17: 877–881.PubMedCrossRefGoogle Scholar
  38. 38.
    Kubota K, Yamada S, Ishiwata K, et al. Evaluation of the treatment response of lung cancer with positron emission tomography and L-methyl-1 1 C methionine:a preliminary study. Eur J Nucl Med 1993; 20: 495–501.PubMedCrossRefGoogle Scholar
  39. 39.
    Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-(F-18)-2-Deoxy-D glucose. Radiology 1994; 191: 379–382.PubMedGoogle Scholar
  40. 40.
    Kim EE, Garcia JR, Wong FCL, et al. Differentiation of thoracic tumors from posttreatment changes using PET with F-18 FDG and C-11 Methionine. J Nucl Med 1994; 35: 76 P.Google Scholar
  41. 41.
    Engenhart R, Kimmig BN, Strauss LG, et al. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlen-ther Onkol 1992; 168: 203–212.Google Scholar
  42. 42.
    Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991; 32: 1655–1660.PubMedGoogle Scholar
  43. 43.
    Lowe VJ, Hebert ME, Hawk TC, Anscher MS, Coleman RE. Chestwall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma. J Nucl Med 1994; 35: 76 P.Google Scholar
  44. 44.
    Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995.Google Scholar
  45. 45.
    Kubota K, Kubota R, Yamada S, Tada M. Effects of radiotherapy on the cellular uptake of carbon-14 labeled L-methionine in tumor tissue. Nucl Med Biol 1995.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Kazuo Kubota
  • Susumu Yamada
  • Masatoshi Ito
  • Kenji Yamada
  • Takehiko Fujiwara
  • Roko Kubota
  • Kiichi Ishiwata
  • Hiroshi Fukuda
  • Taiju Matsuzawa
  • Masao Tada
  • Tatsuo Ido

There are no affiliations available

Personalised recommendations